HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Moglie Le Quintrec Selected Research

Complement C3 Nephritic Factor

1/2018Patterns of Clinical Response to Eculizumab in Patients With C3 Glomerulopathy.
6/2015Anti-factor H autoantibodies in C3 glomerulopathies and in atypical hemolytic uremic syndrome: one target, two diseases.
8/2012Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Moglie Le Quintrec Research Topics

Disease

8Atypical Hemolytic Uremic Syndrome
05/2022 - 09/2010
7Inflammation (Inflammations)
11/2021 - 06/2014
6Glomerulonephritis
12/2023 - 08/2012
6Infections
01/2022 - 11/2016
5Kidney Diseases (Kidney Disease)
11/2023 - 03/2015
4Hemolytic-Uremic Syndrome
02/2024 - 12/2010
4Thrombotic Microangiopathies
11/2023 - 12/2010
4Chronic Renal Insufficiency
01/2023 - 01/2018
4Neoplasms (Cancer)
01/2023 - 11/2016
4Nephrotic Syndrome (Syndrome, Nephrotic)
01/2023 - 03/2015
3Rare Diseases (Rare Disease)
05/2024 - 10/2016
3Chronic Kidney Failure (Chronic Renal Failure)
09/2023 - 01/2021
3Membranous Glomerulonephritis (Membranous Nephropathy)
01/2023 - 03/2021
3Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II)
04/2022 - 08/2012
3COVID-19
01/2022 - 01/2021
3Acute Kidney Injury (Acute Renal Failure)
01/2021 - 11/2009
3Proteinuria
01/2021 - 01/2018
3Paraproteinemias (Monoclonal Gammopathy)
01/2018 - 06/2015
2Vasculitis (Vasculitides)
01/2022 - 06/2014
2Ischemia
11/2021 - 04/2018
2Thrombosis (Thrombus)
01/2019 - 05/2013
1Hematologic Neoplasms (Hematological Malignancy)
02/2024
1Bacterial Infections (Bacterial Infection)
02/2024
1Systemic Scleroderma (Systemic Sclerosis)
02/2024
1Amyloidosis
09/2023
1Renal Insufficiency (Renal Failure)
09/2023
1Diabetes Mellitus
01/2023
1Hypertension (High Blood Pressure)
05/2022
1Mastocytosis
04/2022
1Incisional Hernia
03/2022
1Pathologic Complete Response
01/2022
1Lupus Nephritis
12/2021
1Polyneuropathies (Polyneuropathy)
12/2021
1IgA Vasculitis (Purpura, Schoenlein Henoch)
03/2021
1IGA Glomerulonephritis (IGA Nephropathy)
03/2021
1Interstitial Nephritis (Tubulointerstitial Nephritis)
03/2021
1Lipoid Nephrosis (Glomerulonephritis, Minimal Change)
03/2021
1Rhabdomyolysis
01/2021
1Cicatrix (Scar)
01/2021
1Convalescence
01/2021
1Disease Progression
11/2020
1Vascular System Injuries
01/2020
1Pancreatitis
01/2019
1Autoimmune Diseases (Autoimmune Disease)
01/2019
1Multiple Myeloma
04/2018
1Vascular Diseases (Vascular Disease)
01/2018
1Muscle Weakness
01/2018
1Fibrosis (Cirrhosis)
01/2018
1Crohn Disease (Crohn's Disease)
12/2017

Drug/Important Bio-Agent (IBA)

17Complement System Proteins (Complement)IBA
05/2024 - 09/2010
5Immunoglobulin G (IgG)IBA
01/2022 - 01/2017
5Proteins (Proteins, Gene)FDA Link
12/2021 - 06/2015
5eculizumabFDA Link
01/2021 - 06/2014
4Immunoglobulins (Immunoglobulin)IBA
11/2023 - 01/2017
4AutoantibodiesIBA
12/2021 - 12/2010
4Complement Factor H (Factor H)IBA
04/2018 - 12/2010
3Shiga Toxin (Shigella Toxin)IBA
02/2024 - 03/2012
3CreatinineIBA
01/2023 - 01/2018
3CytokinesIBA
01/2022 - 01/2019
3AntigensIBA
12/2021 - 10/2016
3AntibodiesIBA
12/2021 - 01/2019
3Complement C3 Nephritic FactorIBA
01/2018 - 08/2012
2Complement Membrane Attack Complex (Membrane Attack Complex)IBA
01/2023 - 01/2018
2SteroidsIBA
01/2022 - 01/2018
2Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
01/2022 - 03/2021
2Biomarkers (Surrogate Marker)IBA
11/2020 - 01/2020
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2024
1GemcitabineFDA Link
02/2024
1chemotactic factor inactivatorIBA
11/2023
1C-Reactive ProteinIBA
09/2023
1AA amyloidosisIBA
09/2023
1Vitamin DFDA LinkGeneric
01/2023
1Mycophenolic Acid (Cellcept)FDA LinkGeneric
04/2022
1midostaurinIBA
04/2022
1Protein Kinases (Protein Kinase)IBA
04/2022
1Dexamethasone (Maxidex)FDA LinkGeneric
04/2022
1Interleukin-12 (IL 12)IBA
01/2022
1Contactin 1IBA
12/2021
1VaccinesIBA
09/2021
1Influenza Vaccines (Influenza Vaccine)FDA Link
09/2021
1TinIBA
03/2021
1Interleukin-2 (IL2)IBA
01/2021
1Membrane Proteins (Integral Membrane Proteins)IBA
01/2021
1Interleukin-5 (Interleukin 5)IBA
01/2021
1Interleukin-6 (Interleukin 6)IBA
01/2021
1Immunoglobulin M (IgM)IBA
01/2021
1HemopexinIBA
01/2021
1Heme (Haem)IBA
01/2021
1interleukin-21 (interleukin 21)IBA
01/2021
1Complement C3 (C3 Complement)IBA
01/2021
1Complement Factor D (Factor D)IBA
01/2018
1AlbuminsIBA
01/2018
1Monoclonal AntibodiesIBA
12/2017

Therapy/Procedure

6Therapeutics
12/2023 - 06/2014
6Kidney Transplantation
09/2023 - 01/2011
6Transplantation
09/2023 - 01/2011
1Biological Therapy
09/2023
1Herniorrhaphy
03/2022
1Organ Transplantation
01/2019
1Plasma Exchange
01/2018